GenoMed

GenoMed is a biotechnology company that pioneered the concept of "Next Generation Medicine" by applying genomics to the treatment of common, polygenic diseases. The company's core strategy involves using its proprietary Genomic Search Engine to identify genetic markers associated with disease progression and then repurposing existing FDA-approved drugs, specifically ACE inhibitors, to mitigate those risks. GenoMed's clinical focus spanned a wide range of conditions, including chronic kidney disease, diabetes, and viral infections such as West Nile Virus and influenza. Despite its innovative approach to clinical genomics and personalized medicine, the company faced significant regulatory and financial hurdles, leading to the revocation of its public registration. The company's business model was centered on providing genomic-based treatment protocols directly to patients and healthcare providers.